Subscribe
genetic-dna
adike / shutterstock.com
1 December 2016Americas

Broad Institute and UCB to face off at CRISPR interference hearing

An interference proceeding on the patent rights to CRISPR/Cas9 will take place on December 6, with the judges setting the definition of the disputed invention as “the use of CRISPR in a method in a eukaryotic cell”.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Broad Institute signs deals to boost medical research
12 October 2017   The Broad Institute of Harvard and MIT has committed itself to tackling complex therapeutic challenges concerning unmet medical needs, while also signing a deal on technology.


Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Americas
Broad Institute signs deals to boost medical research
12 October 2017   The Broad Institute of Harvard and MIT has committed itself to tackling complex therapeutic challenges concerning unmet medical needs, while also signing a deal on technology.

More on this story

Americas
Broad Institute signs deals to boost medical research
12 October 2017   The Broad Institute of Harvard and MIT has committed itself to tackling complex therapeutic challenges concerning unmet medical needs, while also signing a deal on technology.

More features

Gilead scores win in fake HIV drug dispute
Polsinelli grows roster with ex-corporate counsel
‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird
Sandoz wins $137.2m payout for lost profits in generic launch
Sanofi signs global rights deal to develop rare cancer therapy
Unified Patent Court visualised: Cases, divisions, and classes in charts
WBD to merge with firm to create ‘powerhouse’ practice
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers